This inventor holds 1 USPTO granted patent. Top assignee: Genoscience Pharma. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Madani Rachid: Innovator in Medicinal Chemistry
Introduction
Madani Rachid is a notable inventor based in Saint-Cyr-sur-Mer, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of new treatments for fibrosis and related diseases. His innovative work has led to the creation of a patent that addresses critical health issues.
Latest Patents
Madani Rachid holds a patent for "Substituted 2,4 diamino-quinoline as new medicament for fibrosis, autophagy and cathepsins B (CTSB), L (CTSL) and D (CTSD) related diseases." This patent includes 2-primary amino-4-secondary amino-quinoline derivatives, their manufacture, pharmaceutical compositions comprising them, and their use as medicaments. The compounds developed are useful in treating and/or decreasing the severity and/or progression of fibrosis and related diseases. They also serve as medicaments for treating, decreasing the severity and/or progression of, and/or preventing autophagy and related diseases, as well as for inhibiting autophagy flux and cathepsins B, L, and D.
Career Highlights
Madani Rachid is associated with Genoscience Pharma, where he continues to advance his research and development efforts. His work is pivotal in the pharmaceutical industry, focusing on innovative solutions for complex medical conditions.
Collaborations
He collaborates with esteemed colleagues such as Philippe Halfon and Firas Bassissi, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Madani Rachid's contributions to medicinal chemistry and his innovative patent highlight his commitment to improving health outcomes through scientific research. His work exemplifies the impact of dedicated inventors in the field of medicine.